Gero Company
GERO is an AI Drug Discovery company created to solve chronic diseases. To date, Gero has raised approximately $19 million in total capital through a combination of equity rounds and SAFEs.
Headquarters:
Singapore,Central Region,Singapore,Asia
Total Funding:
18700000
Founded Date:
2018-01-01
Last Funding Date:
2024-01-08
Technology:
Data & Analytics
Employee Number:
25
Industry:
AI in Finance




